Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Lusher

Showing results (121-130 of 139) with videos related to

Pageof 14
Sort By:
Clinical Chemistry|October 1, 1971
Automated dithionite test for rapid, inexpensive detection of hemoglobin S and non-S sickling hemoglobinopathiesR M Nalbandian, B M Nichols, F R Camp, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 24, 1999
A randomized, double-blind comparison of two dosage levels of recombinant factor VIIa in the treatment of joint, muscle and mucocutaneous haemorrhages in persons with haemophilia A and B, with and without inhibitors. rFVIIa Study GroupJ M Lusher, H R Roberts, G Davignon, et al.
Blood|August 1, 1992
Effect of age on human immunodeficiency virus type 1-induced changes in lymphocyte populations among persons with congenital clotting disorders. Transfusion Safety Study GroupM A Fletcher, J W Mosley, J Hassett, et al.
The New England Journal of Medicine|February 11, 1993
Low CD4+ counts in a study of transfusion safety. The Transfusion Safety Study GroupL M Aledort, E A Operskalski, S L Dietrich, et al.
Progress in Clinical and Biological Research|January 1, 1984
Panel discussion on the treatment of patients with factor VIII inhibitorsJ M Lusher, M E Eyster, M W Hilgartner, et al.
BMJ (Clinical Research Ed.)|January 25, 1992
Variability in serial CD4 counts and relation to progression of HIV-I infection to AIDS in haemophilic patients. Transfusion Safety Study GroupL M Aledort, M W Hilgartner, M C Pike, et al.
Blood|November 1, 1983
Autoplex versus proplex: a controlled, double-blind study of effectiveness in acute hemarthroses in hemophiliacs with inhibitors to factor VIIIJ M Lusher, P M Blatt, J A Penner, et al.
Archives of Internal Medicine|June 1, 1989
The use of porcine factor VIII concentrate (Hyate:C) in the treatment of patients with inhibitor antibodies to factor VIII. A multicenter US experienceD B Brettler, A D Forsberg, P H Levine, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 24, 1999
Anaphylactic response to factor IX replacement therapy in haemophilia B patients: complete gene deletions confer the highest riskE C Thorland, J B Drost, J M Lusher, et al.
Thrombosis and Haemostasis|September 1, 1995
Comparison of six commercial plasma references for factor VIII, factor IX and von Willebrand factor. On behalf of the Subcommittee for Factor VIII and IX of the Scientific and Standardization Committee of the ISTHC K Kasper, D L Aronson, G Davignon, et al.
Pageof 14

Showing results (121-130 of 139) with videos related to

Sort By:
Pageof 14
Clinical Chemistry|October 1, 1971
Automated dithionite test for rapid, inexpensive detection of hemoglobin S and non-S sickling hemoglobinopathiesR M Nalbandian, B M Nichols, F R Camp, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 24, 1999
A randomized, double-blind comparison of two dosage levels of recombinant factor VIIa in the treatment of joint, muscle and mucocutaneous haemorrhages in persons with haemophilia A and B, with and without inhibitors. rFVIIa Study GroupJ M Lusher, H R Roberts, G Davignon, et al.
Blood|August 1, 1992
Effect of age on human immunodeficiency virus type 1-induced changes in lymphocyte populations among persons with congenital clotting disorders. Transfusion Safety Study GroupM A Fletcher, J W Mosley, J Hassett, et al.
The New England Journal of Medicine|February 11, 1993
Low CD4+ counts in a study of transfusion safety. The Transfusion Safety Study GroupL M Aledort, E A Operskalski, S L Dietrich, et al.
Progress in Clinical and Biological Research|January 1, 1984
Panel discussion on the treatment of patients with factor VIII inhibitorsJ M Lusher, M E Eyster, M W Hilgartner, et al.
BMJ (Clinical Research Ed.)|January 25, 1992
Variability in serial CD4 counts and relation to progression of HIV-I infection to AIDS in haemophilic patients. Transfusion Safety Study GroupL M Aledort, M W Hilgartner, M C Pike, et al.
Blood|November 1, 1983
Autoplex versus proplex: a controlled, double-blind study of effectiveness in acute hemarthroses in hemophiliacs with inhibitors to factor VIIIJ M Lusher, P M Blatt, J A Penner, et al.
Archives of Internal Medicine|June 1, 1989
The use of porcine factor VIII concentrate (Hyate:C) in the treatment of patients with inhibitor antibodies to factor VIII. A multicenter US experienceD B Brettler, A D Forsberg, P H Levine, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 24, 1999
Anaphylactic response to factor IX replacement therapy in haemophilia B patients: complete gene deletions confer the highest riskE C Thorland, J B Drost, J M Lusher, et al.
Thrombosis and Haemostasis|September 1, 1995
Comparison of six commercial plasma references for factor VIII, factor IX and von Willebrand factor. On behalf of the Subcommittee for Factor VIII and IX of the Scientific and Standardization Committee of the ISTHC K Kasper, D L Aronson, G Davignon, et al.
Pageof 14